Javascript must be enabled to continue!
Torsade de pointes due to coxsackie B3 myocarditis
View through CrossRef
AbstractViral myocarditis may present with a variety of electrocardiologic aberrations. Torsade de pointes, a potentially malignant ventricular arrhythmia associated with prolongation of the QT interval has not been described in patients with acute viral myocarditis. This report details this finding in a patient with coxsackie B3 myocarditis in whom symptomatic torsade de pointes was documented.
Title: Torsade de pointes due to coxsackie B3 myocarditis
Description:
AbstractViral myocarditis may present with a variety of electrocardiologic aberrations.
Torsade de pointes, a potentially malignant ventricular arrhythmia associated with prolongation of the QT interval has not been described in patients with acute viral myocarditis.
This report details this finding in a patient with coxsackie B3 myocarditis in whom symptomatic torsade de pointes was documented.
Related Results
Integrated Bioinformatics analysis and Metabolomic Responses in finding novel therapeutic approach to treat viral myocarditis
Integrated Bioinformatics analysis and Metabolomic Responses in finding novel therapeutic approach to treat viral myocarditis
Abstract
Background
Myocarditis is one of the most common health problems in young people. Despite imaging...
Immune checkpoint inhibitor-associated myocarditis: diagnostic challenges
Immune checkpoint inhibitor-associated myocarditis: diagnostic challenges
Abstract
Background
Immune checkpoint inhibitors (ICIs), which are increasingly used in cancer pharmacotherapy, can induce myoca...
Evolution of Myocarditis Incidence at a Large Healthcare System Before and During COVID-19 Pandemic
Evolution of Myocarditis Incidence at a Large Healthcare System Before and During COVID-19 Pandemic
Abstract
Background
Myocarditis is a recognized complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in...
Myocarditis Associated with COVID-19 Vaccination
Myocarditis Associated with COVID-19 Vaccination
Myocarditis after the COVID-19 vaccine is one of the important adverse events following immunization, observed mainly after mRNA-based vaccines. Importantly, post-vaccination myoca...
Evaluating risk factors, biomarkers and management of myocarditis following treatment with checkpoint inhibitors. A retrospective analysis
Evaluating risk factors, biomarkers and management of myocarditis following treatment with checkpoint inhibitors. A retrospective analysis
Abstract
Immunotherapy is an exciting treatment of many malignancies. They upregulate the immune system to attack cancerous ce...
Immune-checkpoint myocarditis phenotype when using systematic troponin surveillance in cancer patients.
Immune-checkpoint myocarditis phenotype when using systematic troponin surveillance in cancer patients.
Abstract
Background
ICI myocarditis, often described as potentially fulminant in registries from specialized centers, lacks suff...
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
Background: Myocarditis and pericarditis cases following Coronavirus 2019 (COVID-19) vaccination were reported worldwide. In Thailand, COVID-19 vaccines were approved for emergency...
P1813Impact of cardiac MRI imaging on detection rates of myocarditis
P1813Impact of cardiac MRI imaging on detection rates of myocarditis
Abstract
Background
The Lake Louise Criteria for the diagnosis of myocarditis by cardiac MRI (CMR) was published in 2009 (JACC A...

